Company intelligence / Profile preview

OnLume

Madison, Wisconsin, United Statesonlume.com ↗

Ownership: Private
Development stage: Other

Overview

The OnLume Imaging System received FDA clearance for fluorescence imaging of blood flow and tissue perfusion in multiple surgical specialties. The technology is used in real-world clinical settings, and early applications show improved visualization of critical anatomy and potential for optimized outcomes. Expansion to cancer and nerve margin imaging is in R&D/future pipeline.

Therapeutic areas: OncologyImmunologyCardiovascularOtherGastroenterology
Modalities: Device
Industry: Medical Imaging

Partnerships

WARF VenturesWisconsin Investment PartnersCambridge Investment Group (Luzich Partners LLC)University of Wisconsin–Madison

Beyond the preview

Go deeper on OnLume.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OnLume.

Explore the full profile